ZipLine Medical, Inc., a Campbell, Calif.-based medical device company, completed a $19m round of financing.
The round was led by new investor MVM Life Science Partners with participation from existing investor China Materialia. In conjunction with the funding, Stephen Reeders, M.D., Ph.D., managing partner at MVM, and Bali Muralidhar, M.D., Ph.D., partner at MVM, joined ZipLine’s Board of Directors.
The company intends to use the funds to accelerate worldwide commercialization activities for its Zip® Surgical Skin Closure products.
Founded by Amir Belson, M.D., and led by John Tighe, President and CEO, ZipLine Medical has developed noninvasive surgical skin closure devices for suture-like outcomes. To date, over 25,000 surgical procedures have been performed worldwide across multiple medical specialties with Zip Surgical Skin Closure devices, which are sold in over 30 countries.
Zip® Surgical Skin Closure devices are classified by the U.S. FDA as “Class I, 510(k) Exempt” and have received CE Mark.